UBS Group’s U.S. Equity Cumulative Dividends Fund - Series 2027 IDIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,141
Closed -$23K 11734
2022
Q3
$23K Buy
3,141
+1,772
+129% +$13.4K ﹤0.01% 7233
2022
Q2
$11K Buy
+1,369
New +$11.2K ﹤0.01% 7918
2021
Q1
Sell
-260
Closed -$3K 9720
2020
Q4
$3K Sell
260
-508
-66% -$4.91K ﹤0.01% 8048
2020
Q3
$7K Buy
768
+724
+1,645% +$6.91K ﹤0.01% 7163
2020
Q2
$0 Buy
44
+3
+7% +$27 ﹤0.01% 8528
2020
Q1
$0 Sell
41
-62
-60% -$708 ﹤0.01% 8590
2019
Q4
$1K Buy
+103
New +$1.21K ﹤0.01% 8018
2019
Q3
Sell
-461
Closed -$6K 8387
2019
Q2
$6K Sell
461
-29
-6% -$354 ﹤0.01% 7344
2019
Q1
$6K Sell
490
-324
-40% -$3.92K ﹤0.01% 7117
2018
Q4
$9K Buy
+814
New +$10.2K ﹤0.01% 7307

UBS Group's IDIV Position: Q4 2022 in Review

UBS Group sold out of U.S. Equity Cumulative Dividends Fund - Series 2027 (IDIV) in Q4 2022, closing a stake of 3,141 shares — an estimated $23K sold.

UBS Group first reported a position in IDIV in Q4 2018 and held it in 10 quarters. The position peaked at $23K in Q3 2022. 0 funds tracked by Wall St. Rank hold IDIV as of Q4 2022.

  • UBS Group reported no remaining U.S. Equity Cumulative Dividends Fund - Series 2027 position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 3,141 U.S. Equity Cumulative Dividends Fund - Series 2027 shares in Q4 2022, an estimated $23K.
  • UBS Group first reported a position in U.S. Equity Cumulative Dividends Fund - Series 2027 in Q4 2018 and held it in 10 quarters.
  • UBS Group's U.S. Equity Cumulative Dividends Fund - Series 2027 position peaked at $23K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held U.S. Equity Cumulative Dividends Fund - Series 2027 as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.